Past investments:

• Edgewise Therapeutics
• Syros Pharmaceuticals
• Yisheng Biopharma
• Evox Therapeutics
• Olema Oncology
• Aerin Medical
• CoreMap
• NewMed Medical
• BioShin
• Scribe Therapeutics
• X4 Pharmaceuticals
• Visen Pharmaceuticals
• Abbisko Therapeutics
• Sonendo
• Cullinan Oncology
• Silverback Therapeutics
• Harbour Biomed
• Nuvation Bio
• Century Therapeutics
• GentiBio
• Decibel Therapeutics
• Cytek Biosciences
• Caris Life Sciences
• UNUM Therapeutics
• Scorpion Therapeutics
• Crossover Health
• PMV Pharmaceuticals
• Immvira
• Verona Pharma
• Adagio Therapeutics
• Zhaoke Ophthalmology Pharmaceutical
• Pandion Therapeutics
• Adimab
• Cleave Therapeutics
• Adicet Bio
• BlossomHill Therapeutics
• SI-BONE
• Ikena Oncology
• AbCellera Biologics
• Nucleix
• Aspen Neuroscience
• VectivBio
• GrayBug
• ReViral
• Harmony Biosciences
• Graphite Bio
• RayzeBio
• Erasca
• MobileODT
• Terns Pharmaceuticals
• Repare Therapeutics
• AnchorDx
• Ventyx Biosciences
• Clover Biopharmaceuticals
• Protekt Therapeutics
• Nuohui Health
• I-Mab Biopharma
• InventisBio
• Prelude Therapeutics
• Sublimity Therapeutics
• Gracell Biotechnologies
• Ruipeng Pet Healthcare
• Loxo Oncology
• Janux Therapeutics
• ImmPACT Bio USA
• ORIC Pharmaceuticals
• MBX Biosciences
• Enliven Therapeutics
• Acutus Medical
• Foamix
• Miaoshou Doctor
• Delfi Diagnostics
• Rongchang Pharmaceutical
• Remegen
• Noctrix Health
• Tricida
• MabPlex International
• Passage Bio
• Chinook Therapeutics
• Keros Therapeutics
• Alizé Pharma
• Chemomab
• MDClone
• Fore Biotherapeutics
• VelosBio
• Achilles Therapeutics
• Galecto
• NeuroPace
• Kinnate Biopharma
• Q32 Bio
• Azura Ophthalmics
• ReCode Therapeutics
• TytoCare
• Clementia Pharmaceuticals
• Imara
• ESCAPE Bio
• Arcutis Biotherapeutics